Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMPYJLA)

Drug Name
Methotrexate gamma-L-proline-hydroxamic acid Drug Info
Synonyms CHEMBL388879; methotrexate gamma-L-proline-hydroxamic acid
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
44428667
TTD Drug ID
DMPYJLA

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Approved Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Matrix metalloproteinase-9 (MMP-9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Curcumin DMQPH29 Solid tumour/cancer 2A00-2F9Z Phase 3 [2]
DP-b99 DM97S10 Stroke 8B20 Phase 3 [3]
GS-5745 DMP8MDW Gastric adenocarcinoma 2B72 Phase 3 [4]
Andecaliximab DMLDB1X Gastric adenocarcinoma 2B72 Phase 3 [5]
BLZ-100 DMFKA4G Glioma 2A00.0 Phase 1/2 [6]
Neovastat DMXTYWJ Non-small-cell lung cancer 2C25.Y Phase 1 [7]
PMID29130358-Compound-Figure18(14a) DMHIBTZ N. A. N. A. Patented [8]
PMID29130358-Compound-Figure17(12) DMML4PA N. A. N. A. Patented [8]
PMID29130358-Compound-Figure17(10) DMVA15O N. A. N. A. Patented [8]
PMID29130358-Compound-SB-3CT DMC64XQ N. A. N. A. Patented [8]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting Matrix metalloproteinase-2 (MMP-2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Prinomastat DM9HOKG Lung cancer 2C25.0 Approved [9]
Epigallocatechin gallate DMCGWBJ Hepatic fibrosis DB93.0 Phase 3 [10]
Marimastat DM6V34C Pancreatic cancer 2C10 Phase 3 [11]
Neovastat DMXTYWJ Non-small-cell lung cancer 2C25.Y Phase 1 [7]
Metastat DMTQ4PN Acne vulgaris ED80 Phase 1 [12]
PMID29130358-Compound-Figure18(14a) DMHIBTZ N. A. N. A. Patented [8]
PMID29130358-Compound-Figure10(2a) DMFWXPS N. A. N. A. Patented [8]
PMID29130358-Compound-Figure16(9b) DMPAQLZ N. A. N. A. Patented [8]
PMID29130358-Compound-SB-3CT DMC64XQ N. A. N. A. Patented [8]
PMID29130358-Compound-Figure16(9a) DMKX5R8 N. A. N. A. Patented [8]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Matrix metalloproteinase-2 (MMP-2) TTLM12X MMP2_HUMAN Inhibitor [1]
Matrix metalloproteinase-9 (MMP-9) TT6X50U MMP9_HUMAN Inhibitor [1]

References

1 Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs. Bioorg Med Chem. 2007 Feb 1;15(3):1266-74.
2 Synthesis and biological evaluation of curcuminoid pyrazoles as new therapeutic agents in inflammatory bowel disease: effect on matrix metalloprote... Bioorg Med Chem. 2009 Feb 1;17(3):1290-6.
3 DP-b99 modulates matrix metalloproteinase activity and neuronal plasticity. PLoS One. 2014 Jun 11;9(6):e99789.
4 National Cancer Institute Drug Dictionary (drug id 747683).
5 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
6 Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov. 2019 May;18(5):339-357.
7 Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials. Semin Oncol. 2001 Dec;28(6):620-5.
8 Gelatinase inhibitors: a patent review (2011-2017).Expert Opin Ther Pat. 2018 Jan;28(1):31-46.
9 AG-3340 (Agouron Pharmaceuticals Inc). IDrugs. 2000 Mar;3(3):336-45.
10 Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4171-4.
11 Metalloelastase (MMP-12) induced inflammatory response in mice airways: effects of dexamethasone, rolipram and marimastat. Eur J Pharmacol. 2007 Mar 15;559(1):75-81.
12 Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer. 2002 Sep;2(9):657-72.